Search Results - "Andersson, Daniel R"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia by Lindgren, Hanna S, Andersson, Daniel R, Lagerkvist, Sören, Nissbrandt, Hans, Cenci, M. Angela

    Published in Journal of neurochemistry (01-03-2010)
    “…J. Neurochem. (2010) 112, 1465-1476. l-DOPA-induced dyskinesia in Parkinson's disease is associated with large increases in brain dopamine (DA) levels…”
    Get full text
    Journal Article
  2. 2

    Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission by Andersson, Daniel R., Nissbrandt, Hans, Bergquist, Filip

    Published in The European journal of neuroscience (01-07-2006)
    “…Previous data indicate that the release of somatodendritic dopamine in substantia nigra influences motor activity and coordination, but the relative importance…”
    Get full text
    Journal Article
  3. 3

    Cerebrospinal fluid neurofilament light chain as a biomarker of neurodegeneration in the Tg4510 and MitoPark mouse models by Clement, Amalie, Mitchelmore, Cathy, Andersson, Daniel R, Asuni, Ayodeji A

    Published in Neuroscience (23-06-2017)
    “…Highlights • Shows evidence for change in brain NF levels in two preclinical models of neurodegeneration (Tg4510 and MitoPark mice). • CSF NF-L discriminates…”
    Get full text
    Journal Article
  4. 4

    The influence of rat strain on the development of neuropathic pain and comorbid anxio-depressive behaviour after nerve injury by Hestehave, Sara, Abelson, Klas S. P., Brønnum Pedersen, Tina, Finn, David P., Andersson, Daniel R., Munro, Gordon

    Published in Scientific reports (01-12-2020)
    “…Back-translating the clinical manifestations of human disease burden into animal models is increasingly recognized as an important facet of preclinical drug…”
    Get full text
    Journal Article
  5. 5

    Efficacy of oral lipid‐based formulations of apomorphine and its diester in a Parkinson's disease rat model by Borkar, Nrupa, Andersson, Daniel R., Yang, Mingshi, Müllertz, Anette, Holm, René, Mu, Huiling

    Published in Journal of pharmacy and pharmacology (01-09-2017)
    “…Objectives Apomorphine is used to symptomatically treat Parkinson's disease (PD). Oral delivery of apomorphine is generally limited by its short plasma…”
    Get full text
    Journal Article
  6. 6

    Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors by Andersson, Daniel R., Björnsson, Evelina, Bergquist, Filip, Nissbrandt, Hans

    Published in Experimental neurology (2010)
    “…Nigro-striatal neurons release dopamine not only from their axon terminals in the striatum, but also from somata and dendrites in the substantia nigra…”
    Get full text
    Journal Article
  7. 7

    Gastrectomy alters emotional reactivity in rats: neurobiological mechanisms by Salomé, Nicolas, Taube, Magdalena, Egecioglu, Emil, Hansson, Caroline, Stenström, Björn, Chen, Duan, Andersson, Daniel R., Georg Kuhn, H., Ohlsson, Claes, Dickson, Suzanne L.

    Published in The European journal of neuroscience (01-05-2011)
    “…Gastrectomy (Gsx) is associated with altered emotional function and a predisposition to depression/anxiety disorders. Here we investigated the effects of Gsx…”
    Get full text
    Journal Article
  8. 8